Authorization of COVID-19 clinical trials: lessons from 2 years of experience of a national competent authority

The COVID-19 pandemic was immediately marked by strong clinical research activity. The French national competent authority presents the data on request for authorization during the first 2 years of COVID-19 pandemic to inform discussions on future clinical research issues. Applications for authoriza...

Descripción completa

Detalles Bibliográficos
Autores principales: Vignot, Stéphane, Dhanani, Alban, Sainte-Marie, Isabelle, de Ligniville Lajavardi, Laure, Even, Gwennaelle, Echemann, Muriel, Hulin, Nina, Ménoret, Claire, Maison, Patrick, Ratignier-Carbonneil, Christelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421368/
https://www.ncbi.nlm.nih.gov/pubmed/36046816
http://dx.doi.org/10.3389/fphar.2022.972660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421368/
https://www.ncbi.nlm.nih.gov/pubmed/36046816
http://dx.doi.org/10.3389/fphar.2022.972660

Ejemplares similares